Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer : summary of the results of a questionnaire survey of oncologists and diabetologists-secondary publication
© The Japan Diabetes Society and the Japanese Cancer Association 2023..
The Japan Diabetes Society (JDS) and the Japan Cancer Association (JCA) launched a joint committee and published their "First Joint Committee Report on Diabetes and Cancer" in 2013, compiling recommendations for physicians and healthcare providers as well as for the general population. In 2016, the "Second Joint Committee Report on Diabetes and Cancer" summarized the current evidence on glycemic control and cancer risk in patients with diabetes. The current "Third Joint Committee Report on Diabetes and Cancer", for which the joint committee also enlisted the assistance of the Japanese Society of Clinical Oncology (JSCO) and the Japanese Society of Medical Oncology (JSMO), reports on the results from the questionnaire survey, "Diabetes Management in Patients Receiving Cancer Therapy," which targeted oncologists responsible for cancer management and diabetologists in charge of glycemic control in cancer patients. The results of the current survey demonstrated that there is a general consensus among oncologists and diabetologists with regard to the need for guidelines on glycemic control goals, the relevance of glycemic control, and glycemic control during cancer therapy in cancer patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Diabetology international - 15(2024), 1 vom: 09. Jan., Seite 5-18 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Goto, Atsushi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Revised 25.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s13340-023-00672-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367546388 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367546388 | ||
| 003 | DE-627 | ||
| 005 | 20240125232143.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240124s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13340-023-00672-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1270.xml |
| 035 | |a (DE-627)NLM367546388 | ||
| 035 | |a (NLM)38264218 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Goto, Atsushi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer |b summary of the results of a questionnaire survey of oncologists and diabetologists-secondary publication |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.01.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Japan Diabetes Society and the Japanese Cancer Association 2023. | ||
| 520 | |a The Japan Diabetes Society (JDS) and the Japan Cancer Association (JCA) launched a joint committee and published their "First Joint Committee Report on Diabetes and Cancer" in 2013, compiling recommendations for physicians and healthcare providers as well as for the general population. In 2016, the "Second Joint Committee Report on Diabetes and Cancer" summarized the current evidence on glycemic control and cancer risk in patients with diabetes. The current "Third Joint Committee Report on Diabetes and Cancer", for which the joint committee also enlisted the assistance of the Japanese Society of Clinical Oncology (JSCO) and the Japanese Society of Medical Oncology (JSMO), reports on the results from the questionnaire survey, "Diabetes Management in Patients Receiving Cancer Therapy," which targeted oncologists responsible for cancer management and diabetologists in charge of glycemic control in cancer patients. The results of the current survey demonstrated that there is a general consensus among oncologists and diabetologists with regard to the need for guidelines on glycemic control goals, the relevance of glycemic control, and glycemic control during cancer therapy in cancer patients | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Glycemic control | |
| 650 | 4 | |a Questionnaire survey | |
| 700 | 1 | |a Ohashi, Ken |e verfasserin |4 aut | |
| 700 | 1 | |a Noda, Mitsuhiko |e verfasserin |4 aut | |
| 700 | 1 | |a Noto, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ueki, Kohjiro |e verfasserin |4 aut | |
| 700 | 1 | |a Inoue, Manami |e verfasserin |4 aut | |
| 700 | 1 | |a Nishimura, Rimei |e verfasserin |4 aut | |
| 700 | 1 | |a Takahashi, Shin |e verfasserin |4 aut | |
| 700 | 1 | |a Ioka, Tatsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Oshima, Masanobu |e verfasserin |4 aut | |
| 700 | 1 | |a Fujibayashi, Kazutoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuji, Akihito |e verfasserin |4 aut | |
| 700 | 1 | |a Kodaira, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Tamakoshi, Akiko |e verfasserin |4 aut | |
| 700 | 1 | |a Mimori, Koshi |e verfasserin |4 aut | |
| 700 | 1 | |a Tanabe, Yuko |e verfasserin |4 aut | |
| 700 | 1 | |a Hara, Eiji |e verfasserin |4 aut | |
| 700 | 1 | |a Matsuo, Keitaro |e verfasserin |4 aut | |
| 700 | 1 | |a Murakami, Yoshinori |e verfasserin |4 aut | |
| 700 | 1 | |a Watada, Hirotaka |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetology international |d 2014 |g 15(2024), 1 vom: 09. Jan., Seite 5-18 |w (DE-627)NLM26457950X |x 2190-1678 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:1 |g day:09 |g month:01 |g pages:5-18 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s13340-023-00672-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 1 |b 09 |c 01 |h 5-18 | ||